I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Eynde, Jean-Jacques Vanden
87
results:
Articles (Online) X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
Potassium permanganate, a versatile reagent for the aromati..:
Eynde, Jean-Jacques Vanden
;
D'Orazio, Rita
;
Van Haverbeke, Yves
Tetrahedron. 50 (1994) 8 - p. 2479-2484 , 1994
Link:
https://doi.org/10.1016/..
?
2
Novel Syntheses of Heterocycles with N-(1-Haloalkyl)Azinium..:
Eynde, Jean-Jacques Vanden
;
Mayence, Annie
;
Maquestiau, André
.
Synthetic Communications. 22 (1992) 21 - p. 3141-3150 , 1992
Link:
https://doi.org/10.1080/..
?
3
Novel syntheses of heterocycles with N-(1-Haloalkyl)azinium..:
Eynde, Jean-Jacques Vanden
;
D'Orazio, Patrizia
;
Mayence, Annie
..
Tetrahedron. 48 (1992) 7 - p. 1263-1268 , 1992
Link:
https://doi.org/10.1016/..
?
4
Novel Syntheses of Heterocycles with N-(1-Haloalkyl)azinium..:
Eynde, Jean-Jacques Vanden
;
Mayence, Annie
;
Maquestiau, André
.
Synthetic Communications. 22 (1992) 22 - p. 3291-3304 , 1992
Link:
https://doi.org/10.1080/..
?
5
An Improved One-Pot Method for the Preparation of 2-Substit..:
Maquestiau, André
;
Berte, Laurence
;
Mayence, Annie
.
Synthetic Communications. 21 (1991) 21 - p. 2171-2180 , 1991
Link:
https://doi.org/10.1080/..
?
6
Ultrasound-promoted aromatization of hantzsch 1,4-Dihydropy..:
Maquestiau, Andrè
;
Mayence, Annie
;
Eynde, Jean-Jacques Vanden
Tetrahedron Letters. 32 (1991) 31 - p. 3839-3840 , 1991
Link:
https://doi.org/10.1016/..
?
7
Drugs and Drug Candidates: Year in Review:
Vanden Eynde, Jean Jacques
Drugs and Drug Candidates. 3 (2024) 1 - p. 52-53 , 2024
Link:
https://doi.org/10.3390/..
?
8
Repositioning Oxybutynin Hydrochloride: State of the Art in..:
Vanden Eynde, Jean Jacques
Drugs and Drug Candidates. 2 (2023) 4 - p. 865-882 , 2023
Link:
https://doi.org/10.3390/..
?
9
COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now–..:
Vanden Eynde, Jean Jacques
Pharmaceuticals. 14 (2021) 7 - p. 664 , 2021
Link:
https://doi.org/10.3390/..
?
10
Dual-Target Inhibitors of the Folate Pathway Inhibit Intrin..:
Toulouse, Jacynthe L.
;
Shi, Genbin
;
Lemay-St-Denis, Claudèle
...
ACS Medicinal Chemistry Letters. 11 (2020) 11 - p. 2261-2267 , 2020
Link:
https://doi.org/10.1021/..
?
11
COVID-19: A Brief Overview of the Discovery Clinical Trial:
Vanden Eynde, Jean Jacques
Pharmaceuticals. 13 (2020) 4 - p. 65 , 2020
Link:
https://doi.org/10.3390/..
?
12
2019: An Awesome Year for Pharmaceuticals:
Vanden Eynde, Jean Jacques
Pharmaceuticals. 13 (2020) 1 - p. 6 , 2020
Link:
https://doi.org/10.3390/..
?
13
COVID-19: An Update about the Discovery Clinical Trial:
Vanden Eynde, Jean Jacques
Pharmaceuticals. 13 (2020) 5 - p. 98 , 2020
Link:
https://doi.org/10.3390/..
?
14
Breakthroughs in Medicinal Chemistry: New Targets and Mecha..:
Gütschow, Michael
;
Vanden Eynde, Jean Jacques
;
Jampilek, Josef
...
Molecules. 25 (2020) 13 - p. 2968 , 2020
Link:
https://doi.org/10.3390/..
?
15
Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radi..:
Mayence, Annie
;
Vanden Eynde, Jean Jacques
Pharmaceuticals. 12 (2019) 3 - p. 115 , 2019
Link:
https://doi.org/10.3390/..
1-15